Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AIM Vaccine Co., Ltd. Class H ( (HK:6660) ) just unveiled an announcement.
AIM Vaccine Co., Ltd. has announced the composition of its board of directors and their respective roles within the company. The board includes a mix of executive, non-executive, and independent non-executive directors, with Mr. Yan Zhou serving as the Chairman and CEO. The announcement outlines the structure of five board committees, highlighting the leadership and membership roles of each director. This organizational update reflects AIM Vaccine’s commitment to robust governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
More about AIM Vaccine Co., Ltd. Class H
AIM Vaccine Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the vaccine industry, focusing on the development and distribution of vaccines.
YTD Price Performance: -47.72%
Average Trading Volume: 6,404,183
Technical Sentiment Signal: Buy
See more insights into 6660 stock on TipRanks’ Stock Analysis page.